Header Logo

Jeffrey Rade

Concepts (387)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Aspirin
10
2025
173
3.210
Why?
Thromboxane B2
8
2025
17
3.150
Why?
Platelet Aggregation Inhibitors
13
2021
218
2.830
Why?
Coronary Artery Bypass
7
2017
277
2.000
Why?
Graft Occlusion, Vascular
6
2016
60
1.740
Why?
Blood Platelets
7
2021
101
1.700
Why?
Saphenous Vein
5
2016
46
1.640
Why?
Thrombomodulin
8
2011
16
1.620
Why?
Acute Coronary Syndrome
6
2021
253
1.430
Why?
Thromboxanes
5
2024
9
1.430
Why?
Myocardial Infarction
11
2020
872
1.390
Why?
Percutaneous Coronary Intervention
9
2021
170
1.390
Why?
Coronary Artery Disease
6
2021
276
1.230
Why?
Heart Failure
4
2025
872
1.080
Why?
Thromboxane A2
2
2017
5
1.020
Why?
Thrombosis
6
2020
191
1.000
Why?
Cardiac Catheterization
5
2021
257
0.950
Why?
Venous Thrombosis
4
2011
109
0.900
Why?
Cardiovascular Diseases
3
2022
847
0.890
Why?
Ticlopidine
3
2013
47
0.860
Why?
Endothelial Cells
3
2011
178
0.840
Why?
Angioplasty, Balloon, Coronary
5
2020
168
0.790
Why?
Endothelium, Vascular
6
2009
172
0.770
Why?
Biomarkers
8
2025
1348
0.750
Why?
Platelet Activation
5
2019
32
0.700
Why?
Mechanotransduction, Cellular
2
2011
28
0.690
Why?
Ventricular Function, Left
1
2022
263
0.690
Why?
Myocardial Revascularization
1
2020
72
0.690
Why?
Jugular Veins
4
2011
32
0.680
Why?
Myocardial Ischemia
2
2012
111
0.660
Why?
Coronary Disease
3
2014
256
0.650
Why?
Male
39
2025
28501
0.650
Why?
Purinergic P2Y Receptor Antagonists
3
2021
13
0.640
Why?
ST Elevation Myocardial Infarction
4
2021
77
0.640
Why?
Risk Factors
11
2025
5163
0.630
Why?
Middle Aged
25
2025
16897
0.630
Why?
Electrocardiography
2
2020
534
0.620
Why?
Humans
54
2025
61061
0.620
Why?
Aged
22
2025
13890
0.600
Why?
Time Factors
14
2020
3667
0.600
Why?
Fractional Flow Reserve, Myocardial
2
2015
13
0.580
Why?
Platelet Factor 4
2
2009
11
0.570
Why?
NF-kappa B
3
2009
463
0.550
Why?
Human Umbilical Vein Endothelial Cells
2
2018
39
0.550
Why?
Receptors, Purinergic P2Y12
2
2013
4
0.540
Why?
Heparin
2
2009
112
0.530
Why?
Creatinine
3
2024
131
0.520
Why?
Treatment Outcome
15
2020
5355
0.490
Why?
Female
29
2025
31771
0.480
Why?
Stress, Mechanical
3
2011
111
0.460
Why?
Pyridines
1
2014
98
0.450
Why?
Cells, Cultured
11
2021
2114
0.450
Why?
Cyclooxygenase 1
1
2013
18
0.440
Why?
Hematocrit
1
2013
33
0.440
Why?
Adenoviridae
9
2008
120
0.410
Why?
Stroke Volume
3
2025
324
0.390
Why?
Blood Pressure
2
2006
541
0.390
Why?
Drug Resistance, Multiple
1
2012
33
0.390
Why?
Genetic Therapy
5
2008
743
0.380
Why?
Anterior Wall Myocardial Infarction
1
2011
5
0.380
Why?
Quinazolines
1
2011
22
0.370
Why?
Risk Assessment
6
2025
1957
0.370
Why?
Transforming Growth Factor beta1
1
2011
54
0.370
Why?
Thiophenes
1
2011
30
0.370
Why?
Drug Resistance
1
2011
95
0.360
Why?
Piperazines
1
2011
83
0.360
Why?
Myocardium
3
2020
265
0.360
Why?
Fatty Acid-Binding Proteins
1
2010
21
0.360
Why?
Drug-Eluting Stents
1
2011
54
0.360
Why?
Matrix Metalloproteinase 1
2
2021
8
0.340
Why?
Receptor, PAR-1
2
2020
4
0.330
Why?
Antibodies, Neutralizing
1
2011
192
0.330
Why?
Proteasome Inhibitors
1
2009
30
0.330
Why?
Cyclooxygenase 2
1
2009
75
0.330
Why?
Boronic Acids
1
2009
28
0.320
Why?
Pyrazines
1
2009
33
0.320
Why?
Kruppel-Like Transcription Factors
1
2009
49
0.320
Why?
Fibroblast Growth Factor 4
2
2008
7
0.320
Why?
Gene Expression Regulation
4
2005
1555
0.320
Why?
Gene Expression Regulation, Enzymologic
1
2009
132
0.320
Why?
Platelet Aggregation
4
2013
27
0.310
Why?
Protease Inhibitors
1
2009
104
0.310
Why?
Prognosis
3
2024
1631
0.300
Why?
Prasugrel Hydrochloride
3
2021
13
0.300
Why?
Hirudins
3
1999
9
0.300
Why?
Angina Pectoris
2
2005
38
0.300
Why?
Atherosclerosis
2
2021
149
0.300
Why?
Neovascularization, Physiologic
2
2008
103
0.290
Why?
Surgical Procedures, Operative
1
2008
139
0.280
Why?
Endocardium
1
2006
12
0.280
Why?
Genetic Vectors
10
2008
818
0.280
Why?
Stents
2
2020
459
0.270
Why?
Predictive Value of Tests
3
2017
1061
0.260
Why?
Heart Rate
3
2006
318
0.260
Why?
Lipopeptides
3
2021
17
0.260
Why?
Follow-Up Studies
5
2020
2406
0.260
Why?
Cell-Penetrating Peptides
3
2021
27
0.260
Why?
Antineoplastic Agents
1
2011
649
0.250
Why?
United States
8
2021
7671
0.250
Why?
Rabbits
4
2011
330
0.240
Why?
Antibody Formation
1
2005
112
0.240
Why?
Multivariate Analysis
2
2017
933
0.230
Why?
Interleukin-1
1
2005
156
0.230
Why?
Tumor Necrosis Factor-alpha
2
2018
589
0.220
Why?
Protein C
3
2011
30
0.220
Why?
Coronary Circulation
3
2011
50
0.220
Why?
Inflammation Mediators
1
2005
170
0.220
Why?
Vascular Patency
2
2016
133
0.220
Why?
Carotid Arteries
4
2011
62
0.220
Why?
Animals
18
2021
19880
0.210
Why?
Angina, Unstable
1
2003
57
0.210
Why?
Cloning, Molecular
1
2003
382
0.210
Why?
Estrogen Replacement Therapy
1
2003
86
0.210
Why?
Feedback, Physiological
1
2003
59
0.200
Why?
Registries
3
2021
811
0.200
Why?
Estrogens
1
2003
115
0.200
Why?
Progesterone
1
2003
160
0.200
Why?
Antithrombins
2
1999
16
0.200
Why?
Retroviridae
2
1999
70
0.200
Why?
Prospective Studies
6
2021
3193
0.200
Why?
Blood Coagulation Factors
1
2002
14
0.200
Why?
Muscle, Smooth, Vascular
4
2011
47
0.190
Why?
Adenosine Diphosphate
2
2013
41
0.190
Why?
Proto-Oncogene Proteins
4
2005
321
0.190
Why?
Kidney
1
2024
420
0.190
Why?
Fibrillar Collagens
1
2021
1
0.190
Why?
Pandemics
3
2020
639
0.180
Why?
Serine Endopeptidases
1
2021
83
0.180
Why?
Troponin
1
2020
37
0.180
Why?
Coronary Angiography
2
2011
180
0.180
Why?
Gene Transfer Techniques
5
2008
307
0.180
Why?
Aorta
1
2021
107
0.170
Why?
Collagen
2
2011
118
0.170
Why?
Receptors, Cell Surface
1
2002
437
0.160
Why?
Out-of-Hospital Cardiac Arrest
1
2020
45
0.160
Why?
Clinical Trials as Topic
2
2015
456
0.160
Why?
Monocytes
1
2021
347
0.160
Why?
Matrix Metalloproteinase 13
1
2018
6
0.150
Why?
Gene Expression
4
1999
818
0.150
Why?
Influenza A virus
1
2019
117
0.150
Why?
Urinalysis
1
2017
34
0.140
Why?
Disease Models, Animal
5
2021
2084
0.140
Why?
Carotid Artery Diseases
1
2018
62
0.140
Why?
Adult
8
2021
16253
0.140
Why?
Aortic Diseases
1
2018
68
0.140
Why?
Coronavirus Infections
1
2020
199
0.140
Why?
Pneumonia, Viral
1
2020
213
0.140
Why?
Cause of Death
1
2017
209
0.130
Why?
Influenza, Human
1
2019
193
0.130
Why?
Cyclooxygenase Inhibitors
2
2013
42
0.130
Why?
Oxidative Stress
2
2016
286
0.130
Why?
Prevalence
1
2020
1322
0.130
Why?
Kaplan-Meier Estimate
1
2017
398
0.130
Why?
Recurrence
3
2021
608
0.130
Why?
Dinoprost
1
2016
19
0.130
Why?
Rats
5
2006
1930
0.130
Why?
Carotid Artery Injuries
1
1996
12
0.130
Why?
Apoptosis
1
2021
1048
0.130
Why?
Atrioventricular Node
3
2006
9
0.130
Why?
Proportional Hazards Models
1
2017
692
0.130
Why?
Hospitalization
2
2021
1322
0.120
Why?
Coronary Stenosis
1
2015
31
0.120
Why?
Neovascularization, Pathologic
1
1996
140
0.120
Why?
Cardiac Care Facilities
1
2014
2
0.110
Why?
Receptors, Thromboxane A2, Prostaglandin H2
1
2013
1
0.110
Why?
Tomography, X-Ray Computed
2
2011
1541
0.110
Why?
Retrospective Studies
3
2020
6206
0.110
Why?
Practice Patterns, Physicians'
1
2019
724
0.110
Why?
Radial Artery
1
2014
50
0.110
Why?
Professional Competence
1
2014
90
0.110
Why?
GTP-Binding Protein alpha Subunits, Gi-Go
2
2004
15
0.100
Why?
Troponin I
2
2010
33
0.100
Why?
Antibody Specificity
1
2012
103
0.100
Why?
Cross Reactions
1
2012
127
0.100
Why?
Stroke
2
2021
1144
0.100
Why?
Aged, 80 and over
6
2021
5289
0.100
Why?
Chromatography, Liquid
1
2012
129
0.100
Why?
Fibrinolytic Agents
3
2018
165
0.100
Why?
Tandem Mass Spectrometry
1
2012
143
0.100
Why?
Aldehyde Reductase
1
2011
4
0.100
Why?
Paracrine Communication
1
2011
16
0.090
Why?
Enzyme-Linked Immunosorbent Assay
1
2012
459
0.090
Why?
Contraindications
1
2011
48
0.090
Why?
Regional Blood Flow
1
2011
109
0.090
Why?
Carcinoid Tumor
1
2011
14
0.090
Why?
Platelet Count
1
2011
25
0.090
Why?
Myocytes, Smooth Muscle
1
2011
60
0.090
Why?
Creatine Kinase, MB Form
1
2010
10
0.090
Why?
Fatty Acid Binding Protein 3
1
2010
4
0.090
Why?
Treatment Failure
1
2011
192
0.090
Why?
Chi-Square Distribution
1
2011
411
0.090
Why?
Polymorphism, Single Nucleotide
1
2013
481
0.090
Why?
Myoglobin
1
2010
27
0.090
Why?
Neoplasm Metastasis
1
2011
197
0.090
Why?
Molecular Sequence Data
3
2013
1976
0.090
Why?
Blotting, Western
2
2021
596
0.090
Why?
Perioperative Care
1
2011
79
0.090
Why?
DNA, Complementary
2
2003
164
0.090
Why?
Health Personnel
1
2014
346
0.090
Why?
Mice, Knockout, ApoE
2
2021
2
0.080
Why?
Shear Strength
1
2009
15
0.080
Why?
Sensitivity and Specificity
1
2012
1128
0.080
Why?
Plaque, Atherosclerotic
2
2021
28
0.080
Why?
Odds Ratio
1
2011
778
0.080
Why?
Mice, Inbred C3H
1
2009
175
0.080
Why?
Bortezomib
1
2009
56
0.080
Why?
Epinephrine
1
2009
42
0.080
Why?
Ventricular Dysfunction, Left
1
2010
161
0.080
Why?
Blood Glucose
1
2011
481
0.080
Why?
Tissue Plasminogen Activator
2
2000
125
0.080
Why?
Thrombocytopenia
1
2009
50
0.080
Why?
Sex Factors
1
2011
986
0.080
Why?
Collateral Circulation
1
2008
22
0.080
Why?
Randomized Controlled Trials as Topic
3
2021
703
0.070
Why?
Survival Rate
2
2014
812
0.070
Why?
Antibodies, Monoclonal
1
2012
862
0.070
Why?
Logistic Models
1
2011
1272
0.070
Why?
Mice, Inbred C57BL
3
2021
3251
0.070
Why?
Serotonin
2
2005
63
0.070
Why?
Base Sequence
2
2003
1310
0.070
Why?
Mice
3
2021
10393
0.070
Why?
Cardiac Surgical Procedures
1
2011
253
0.070
Why?
Bundle of His
1
2006
3
0.070
Why?
Bundle-Branch Block
1
2006
14
0.070
Why?
Myocardial Contraction
1
2006
85
0.070
Why?
Rats, Wistar
1
2006
179
0.070
Why?
Disease Progression
2
2018
1130
0.060
Why?
Amino Acid Sequence
2
2013
1578
0.060
Why?
RNA, Messenger
1
2011
1476
0.060
Why?
Patient Selection
1
2008
465
0.060
Why?
Immune Complex Diseases
1
2005
2
0.060
Why?
Myocardial Stunning
1
2005
6
0.060
Why?
Proto-Oncogene Proteins c-ets
1
2005
20
0.060
Why?
E1A-Associated p300 Protein
1
2005
9
0.060
Why?
Purpura, Thrombocytopenic, Idiopathic
1
2005
17
0.060
Why?
Catecholamines
1
2005
31
0.060
Why?
Chronic Disease
1
2008
757
0.060
Why?
Neuropeptides
1
2005
83
0.060
Why?
Nitric Oxide Donors
1
2003
5
0.060
Why?
Cysteine Proteinase Inhibitors
1
2003
21
0.050
Why?
Vascular Cell Adhesion Molecule-1
1
2003
15
0.050
Why?
E-Selectin
1
2003
18
0.050
Why?
Intercellular Adhesion Molecule-1
1
2003
53
0.050
Why?
Fibroblast Growth Factors
1
2003
67
0.050
Why?
In Vitro Techniques
2
2011
476
0.050
Why?
Sequence Homology, Amino Acid
1
2003
360
0.050
Why?
Vinblastine
1
2003
18
0.050
Why?
Leukopenia
1
2003
17
0.050
Why?
Cohort Studies
1
2009
2522
0.050
Why?
Trans-Activators
1
2005
301
0.050
Why?
Granulocytes
1
2003
69
0.050
Why?
Vasculitis
1
2003
51
0.050
Why?
Double-Blind Method
2
2020
739
0.050
Why?
Tunica Intima
1
2002
14
0.050
Why?
Sequence Analysis, DNA
1
2003
397
0.050
Why?
Thrombin
1
2002
24
0.050
Why?
Models, Animal
1
2003
223
0.050
Why?
Adenoviridae Infections
2
2003
3
0.050
Why?
Promoter Regions, Genetic
1
2005
664
0.050
Why?
Transplantation, Autologous
1
2002
121
0.050
Why?
Drug Therapy, Combination
1
2003
465
0.050
Why?
Postmenopause
1
2003
248
0.050
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
534
0.050
Why?
A549 Cells
1
2021
36
0.050
Why?
Hemodynamics
1
2003
241
0.050
Why?
Cell Line
2
2018
2016
0.050
Why?
North America
1
2021
120
0.050
Why?
Microscopy, Electron, Transmission
1
2021
135
0.050
Why?
Canada
1
2021
151
0.040
Why?
Proof of Concept Study
1
2020
35
0.040
Why?
Antiviral Agents
1
2003
319
0.040
Why?
Fibrosis
1
2021
154
0.040
Why?
Transfection
2
1999
678
0.040
Why?
Stress, Psychological
1
2005
458
0.040
Why?
Signal Transduction
3
2018
2917
0.040
Why?
Transduction, Genetic
1
2002
233
0.040
Why?
Infusions, Intravenous
1
2020
174
0.040
Why?
Reoperation
1
2021
271
0.040
Why?
Nuclear Proteins
1
2005
765
0.040
Why?
Hirudin Therapy
1
1999
1
0.040
Why?
Megakaryocytes
1
1999
18
0.040
Why?
Necrosis
1
2020
142
0.040
Why?
Hospitals, High-Volume
1
2020
32
0.040
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
1999
26
0.040
Why?
Immunohistochemistry
1
2002
861
0.040
Why?
Arrhythmias, Cardiac
1
2000
147
0.040
Why?
Vascular Surgical Procedures
1
2002
245
0.040
Why?
Growth Hormone
1
1999
20
0.040
Why?
Cell Division
1
2000
444
0.040
Why?
Host-Pathogen Interactions
1
2021
238
0.040
Why?
Complement C3
1
2019
60
0.040
Why?
Protein Sorting Signals
1
1999
55
0.040
Why?
Atrial Fibrillation
2
2004
806
0.040
Why?
Extracellular Traps
1
2019
40
0.040
Why?
Toll-Like Receptor 7
1
2019
97
0.040
Why?
Matrix Metalloproteinase Inhibitors
1
2018
7
0.040
Why?
Clinical Trials, Phase II as Topic
1
2018
23
0.040
Why?
Hydroxamic Acids
1
2018
27
0.040
Why?
Hospitals
1
2021
377
0.040
Why?
Blood Vessel Prosthesis
1
1999
212
0.040
Why?
Rats, Sprague-Dawley
2
1997
582
0.040
Why?
Multicenter Studies as Topic
1
2018
131
0.040
Why?
Drug Utilization
1
2019
225
0.040
Why?
Oligopeptides
1
2018
129
0.040
Why?
Mass Spectrometry
1
1999
297
0.040
Why?
Drug Prescriptions
1
2019
191
0.040
Why?
Adenoviruses, Human
1
1997
9
0.030
Why?
Carotid Artery, Common
1
1997
30
0.030
Why?
Transcription Factors
1
2005
1488
0.030
Why?
Comorbidity
1
2020
1116
0.030
Why?
Neutrophils
1
2019
354
0.030
Why?
Recombinant Proteins
2
1996
700
0.030
Why?
Hospital Mortality
1
2021
855
0.030
Why?
Membrane Glycoproteins
1
2019
670
0.030
Why?
Healthcare Disparities
1
2019
332
0.030
Why?
Dose-Response Relationship, Radiation
1
2014
54
0.030
Why?
Mice, Knockout
1
2019
2023
0.030
Why?
Learning Curve
1
2014
31
0.030
Why?
beta-Galactosidase
1
1993
81
0.030
Why?
Binding, Competitive
1
2013
100
0.030
Why?
GTP-Binding Protein alpha Subunit, Gi2
2
2004
5
0.030
Why?
Massachusetts
1
2019
2128
0.030
Why?
Femoral Artery
1
2014
97
0.030
Why?
Models, Biological
2
2011
1151
0.030
Why?
Genetic Association Studies
1
2013
119
0.030
Why?
Protein Structure, Secondary
1
2013
256
0.030
Why?
Amino Acid Substitution
1
2013
250
0.030
Why?
Proteome
1
2013
143
0.020
Why?
Phosphoproteins
1
2013
214
0.020
Why?
Phospholipase C gamma
1
2011
9
0.020
Why?
Mitogen-Activated Protein Kinase 14
1
2011
9
0.020
Why?
Protein Structure, Tertiary
1
2013
668
0.020
Why?
Coronary Artery Bypass, Off-Pump
1
2011
5
0.020
Why?
Platelet Transfusion
1
2011
12
0.020
Why?
Protein Kinase C
1
2011
98
0.020
Why?
Young Adult
1
2021
4436
0.020
Why?
Emergency Treatment
1
2011
54
0.020
Why?
Binding Sites
1
2013
895
0.020
Why?
Reactive Oxygen Species
1
2011
202
0.020
Why?
Adolescent
1
2021
6051
0.020
Why?
Enzyme Inhibitors
1
2011
354
0.020
Why?
Models, Molecular
1
2013
1140
0.020
Why?
Evidence-Based Medicine
1
2011
461
0.020
Why?
Case-Control Studies
1
2011
1090
0.020
Why?
Diabetes Mellitus
1
2011
541
0.020
Why?
Creatine Kinase
1
2005
43
0.020
Why?
Diltiazem
1
2004
3
0.010
Why?
Propanolamines
1
2004
10
0.010
Why?
Digoxin
1
2004
22
0.010
Why?
Sus scrofa
1
2004
27
0.010
Why?
Cardiac Pacing, Artificial
1
2004
34
0.010
Why?
Drug Administration Schedule
1
2005
292
0.010
Why?
Chest Pain
1
2005
84
0.010
Why?
Anti-Arrhythmia Agents
1
2004
95
0.010
Why?
Nitrogen Oxides
1
2003
8
0.010
Why?
Hydrazines
1
2003
10
0.010
Why?
Dithiothreitol
1
2003
18
0.010
Why?
Injections, Intra-Arterial
1
2003
20
0.010
Why?
Survival Analysis
1
2005
565
0.010
Why?
Technetium Tc 99m Sestamibi
1
2003
33
0.010
Why?
Adenosine
1
2003
69
0.010
Why?
Dose-Response Relationship, Drug
1
2005
831
0.010
Why?
Cysteine Endopeptidases
1
2003
92
0.010
Why?
Recombinant Fusion Proteins
1
2004
499
0.010
Why?
Radiopharmaceuticals
1
2003
180
0.010
Why?
Nitric Oxide
1
2003
148
0.010
Why?
Acute Disease
1
2004
675
0.010
Why?
Ultrasonography
1
2004
464
0.010
Why?
HeLa Cells
1
2003
531
0.010
Why?
Diagnosis, Differential
1
2005
941
0.010
Why?
Tomography, Emission-Computed, Single-Photon
1
2003
200
0.010
Why?
Peptide Fragments
1
2003
404
0.010
Why?
Viral Proteins
1
2003
261
0.010
Why?
Transformation, Genetic
1
2000
27
0.010
Why?
Electric Conductivity
1
2000
52
0.010
Why?
Electrophysiology
1
2000
89
0.010
Why?
Papio
1
1999
13
0.010
Why?
Cattle
1
2000
307
0.010
Why?
Swine
1
2000
353
0.010
Why?
Postoperative Complications
1
2005
1189
0.010
Why?
Arteritis
1
1997
4
0.010
Why?
Neutralization Tests
1
1997
125
0.010
Why?
Immunization
1
1997
132
0.010
Why?
Ultraviolet Rays
1
1997
128
0.010
Why?
Antibodies, Viral
1
1997
304
0.010
Why?
Cell Differentiation
1
1999
1316
0.010
Why?
Rats, Inbred F344
1
1993
52
0.010
Why?
Rade's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (387)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_